Whitepaper: Elevating Medical Affairs Insight Management
In February 2024, 195+ Medical Affairs executives answered a survey aimed to identify the main obstacles and opportunities encountered in managing data insights. This new whitepaper, produced in conjunction with Within3, analyses the results of the survey, enriched by in-depth interviews with sector leaders.
Here’s a sneak peak of some of the data and insights from the whitepaper:
- 65% of respondents said it was currently a challenge to organize and analyze data effectively, with 42% recognizing a need for improvement in their insight management techniques.
- 73% cited the “risk to product launch” as a consequence of inadequate insight gathering, underscoring the commercial stakes involved
- “Massive cultural change” is required to master insights that drive strategic decision-making says Katy Curran, Director Medical Affairs, Medical Excellence & Impact, Immunology, UCB.
- Case studies from Spark Therapeutics on how they used natural language processing (NLP) to enhance insight analysis.
- How to refine your insights management - five key steps for success from Within3
Commentary and analysis by leading pharma experts, including:
- Rosana Cabello Moruno, Therapeutic Area Leader (Medical Affairs), Roche Spain
- Katy Curran, Medical Impact Lead Europe, UCB
- Mark Rees-Saunders, Senior Director Global FME, Astellas
- Jan Malo, Country Medical Director, Roche Slovakia
- Michael Kahn, Senior Director, Medical Affairs, Spark Therapeutics
- Lance Hill, CEO, Within3
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.